RVMD vs. NVDA
RVMD (Revolution Medicines, Inc.) and NVDA (NVIDIA Corporation) are both stocks. RVMD operates in Biotechnology (Healthcare), while NVDA operates in Semiconductors (Technology). Over the past 5 years, RVMD returned 35.73%/yr vs 64.29%/yr for NVDA. At a 0.26 correlation, their price movements are largely independent.
Performance
RVMD vs. NVDA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RVMD achieves a 100.95% return, which is significantly higher than NVDA's 14.05% return.
RVMD
- 1D
- 4.02%
- 1M
- 9.89%
- YTD
- 100.95%
- 6M
- 102.61%
- 1Y
- 294.33%
- 3Y*
- 86.64%
- 5Y*
- 35.73%
- 10Y*
- —
NVDA
- 1D
- 3.54%
- 1M
- -5.60%
- YTD
- 14.05%
- 6M
- 20.66%
- 1Y
- 49.84%
- 3Y*
- 70.84%
- 5Y*
- 64.29%
- 10Y*
- 68.59%
RVMD vs. NVDA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
RVMD Revolution Medicines, Inc. | 100.95% | 82.10% | 52.51% | 20.40% | -5.36% | -36.42% | 40.34% |
NVDA NVIDIA Corporation | 14.05% | 38.92% | 171.25% | 239.02% | -50.26% | 125.48% | 91.92% |
Correlation
The correlation between RVMD and NVDA is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Feb 13, 2020 | 0.26 |
Fundamentals
RVMD:
$31.71B
NVDA:
$5.18T
RVMD:
-$7.17
NVDA:
$6.53
RVMD:
21.14
NVDA:
26.51
RVMD:
$0.00
NVDA:
$253.49B
RVMD:
-$4.70M
NVDA:
$187.95B
RVMD:
-$1.34B
NVDA:
$192.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RVMD vs. NVDA — Risk / Return Rank
RVMD
NVDA
RVMD vs. NVDA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Revolution Medicines, Inc. (RVMD) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RVMD | NVDA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.99 | ||
| Sortino ratioReturn per unit of downside risk | +3.58 | ||
| Omega ratioGain probability vs. loss probability | 1.78 | 1.24 | +0.54 |
| Calmar ratioReturn relative to maximum drawdown | 11.88 | 2.48 | +9.40 |
| Martin ratioReturn relative to average drawdown | 28.48 | 5.89 | +22.58 |
Loading charts...
Drawdowns
RVMD vs. NVDA - Drawdown Comparison
The maximum RVMD drawdown since its inception was -73.29%, smaller than the maximum NVDA drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for RVMD and NVDA.
Loading charts...
Drawdown Indicators
| RVMD | NVDA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -73.29% | -89.72% | +16.43% |
Max Drawdown (1Y)Largest decline over 1 year | -24.95% | -20.21% | -4.74% |
Max Drawdown (3Y)Largest decline over 3 years | -48.63% | -36.88% | -11.75% |
Max Drawdown (5Y)Largest decline over 5 years | -57.95% | -66.34% | +8.39% |
Max Drawdown (10Y)Largest decline over 10 years | — | -66.34% | — |
Current DrawdownCurrent decline from peak | -2.21% | -9.77% | +7.56% |
Average DrawdownAverage peak-to-trough decline | -35.66% | -36.17% | +0.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.57% | 8.48% | +2.09% |
Volatility
RVMD vs. NVDA - Volatility Comparison
Revolution Medicines, Inc. (RVMD) has a higher volatility of 13.97% compared to NVIDIA Corporation (NVDA) at 12.97%. This indicates that RVMD's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RVMD | NVDA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.97% | 12.97% | +1.00% |
Volatility (6M)Calculated over the trailing 6-month period | 55.20% | 26.83% | +28.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 67.30% | 35.13% | +32.17% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 62.58% | 51.80% | +10.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 65.75% | 49.87% | +15.88% |
Dividends
RVMD vs. NVDA - Dividend Comparison
RVMD has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.13%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVDA NVIDIA Corporation | 0.13% | 0.02% | 0.03% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% |
RVMD Revolution Medicines, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RVMD vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Revolution Medicines, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RVMD and NVDA have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RVMD has higher volatility (13.97%) compared to NVDA (12.97%). In terms of maximum drawdown, RVMD dropped -73.29% vs NVDA's -89.72%.
RVMD currently has the higher Sharpe Ratio (4.41 vs 1.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RVMD and NVDA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer